| Citation: |
LIANG Chen, MA Yunlong, LIU Xiaoguang. Research Advances in Functions of YB1 in Tumorigenesis and Tumor Progression[J]. Cancer Research on Prevention and Treatment, 2018, 45(4): 253-257. DOI: 10.3971/j.issn.1000-8578.2018.17.1049
|
YB1 is a multifunctional protein participating in a wide variety of cellular processes. In fact, YB1 plays a critical role in the occurrence and development of tumors. Many previous studies indicate that the expression of YB1 is significantly elevated in tumors and correlated to the poor outcome and reoccurrence of tumors. In recent years, further studies continue to focus on the biological functions of YB1 on tumors, such as tumor proliferation, apoptosis, invasion, chemical drug resistance, while some other regulatory mechanism of YB1 on tumor stem cells and inflammation have been investigated in depth. In this paper, we aim to review the recent advances in the functions of YB1 in tumorigenesis and tumor progression.
| [1] |
Lasham A, Print CG, Woolley AG, et al. YB-1: oncoprotein, prognostic marker and therapeutic target?[J]. Biochemical J, 2013, 449(1): 11-23. doi: 10.1042/BJ20121323
|
| [2] |
Kosnopfel C, Sinnberg T, Schittek B. Y-box binding protein 1-A prognostic marker and target in tumour therapy[J]. Eur J Cell Biol, 2014, 93(1-2): 61-70. doi: 10.1016/j.ejcb.2013.11.007
|
| [3] |
Shinkai K, Nakano K, Cui L, et al. Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models[J]. Int J Cancer, 2016, 139(2): 433-45. doi: 10.1002/ijc.30075
|
| [4] |
Miao X, Wu Y, Wang Y, et al. Y-box-binding protein-1(YB-1) promotes cell proliferation, adhesion and drug resistance in diffuse large B-cell lymphoma[J]. Exp Cell Res, 2016, 346(2):157-66. doi: 10.1016/j.yexcr.2016.07.003
|
| [5] |
Zhang X, Ding Z, Mo J, et al. GOLPH3 promotes glioblastoma cell migration and invasion via the mTOR-YB1 pathway in vitro[J]. Mol Carcinog, 2015, 54(11): 1252-63. doi: 10.1002/mc.v54.11
|
| [6] |
Ha B, Lee EB, Cui J, et al. YB-1 overexpression promotes a TGF-β1-induced epithelial-mesenchymal transition via Akt activation[J]. Biochem Biophys Res Commun, 2015, 458(2): 347-51. doi: 10.1016/j.bbrc.2015.01.114
|
| [7] |
Dey A, Robitaille M, Remke M, et al. YB-1 is elevated in medulloblastoma and drives proliferation in Sonic hedgehog-dependent cerebellar granule neuron progenitor cells and medulloblastoma cells[J]. Oncogene, 2016, 35(32): 4256-68. doi: 10.1038/onc.2015.491
|
| [8] |
El-Naggar AM, Veinotte CJ, Cheng H, et al. Translational Activation of HIF1α by YB-1 Promotes Sarcoma Metastasis[J]. Cancer Cell, 2015, 27(5): 682-97. doi: 10.1016/j.ccell.2015.04.003
|
| [9] |
Song YH, Shiota M, Yokomizo A, et al. Twist1 and Y-box-binding protein-1 are potential prognostic factors in bladder cancer[J]. Urol Oncol, 2014, 32(1): 31.e1-7. doi: 10.1016/j.urolonc.2012.11.003
|
| [10] |
Harada M, Kotake Y, Ohhata T, et al. YB-1 promotes transcription of cyclin D1 in human non-small-cell lung cancers[J]. Genes Cells, 2014, 19(6):504-16. doi: 10.1111/gtc.2014.19.issue-6
|
| [11] |
Bendris N, Lemmers B, Blanchard JM. Cell cycle, cytoskeleton dynamics and beyond: the many functions of cyclins and CDK inhibitors[J]. 2015, 14(12): 1786-98. http://www.ncbi.nlm.nih.gov/pubmed/25789852
|
| [12] |
Fujiwara-Okada Y, Matsumoto Y, Fukushi J, et al. Y-box binding protein-1 regulates cell proliferation and is associated with clinical outcomes of osteosarcoma[J]. Br J Cancer, 2013, 108(4): 836-47. doi: 10.1038/bjc.2012.579
|
| [13] |
Kotake Y, Ozawa Y, Harada M, et al. YB1 binds to and represses the p16 tumor suppressor gene[J]. Genes Cells, 2013, 18(11):999-1006. doi: 10.1111/gtc.2013.18.issue-11
|
| [14] |
Kotake Y, Arikawa N, Tahara K, et al. Y-box Binding Protein 1 Is Involved in Regulating the G2/M Phase of the Cell Cycle[J]. Anticancer Res, 2017, 37(4): 1603-8. doi: 10.21873/anticanres
|
| [15] |
Lyabin DN, Eliseeva IA, Ovchinnikov LP. YB-1 protein: functions and regulation[J]. Wiley Interdiscip Rev RNA, 2014, 5(1): 95-110. doi: 10.1002/wrna.1200
|
| [16] |
Pagano C, di Martino O, Ruggiero G, et al. The tumor-associated YB-1 protein: new player in the circadian control of cell proliferation[J]. Oncotarget, 2017, 8(4): 6193-205. https://www.researchgate.net/profile/Viola_Calabro/publication/311773308_The_tumor-associated_YB-1_protein_new_player_in_the_circadian_control_of_cell_proliferation/links/585a887608aeffd7c4fe9048.pdf
|
| [17] |
Shi JH, Cui NP, Wang S, et al. Overexpression of YB1 C-terminal domain inhibits proliferation, angiogenesis and tumorigenicity in a SK-BR-3 breast cancer xenograft mouse model[J]. FEBS Open Bio, 6(1): 33-42.
|
| [18] |
Wang W, Wang HJ, Wang B, et al. The role of the Y box binding protein 1 C-terminal domain in vascular endothelial cell proliferation, apoptosis, and angiogenesis[J]. DNA and Cell Biology, 2016, 35(1): 24-32. doi: 10.1089/dna.2015.2908
|
| [19] |
Hassan M, Watari H, Abualmaaty A, et al. Apoptosis and molecular targeting therapy in cancer[J]. Biomed Res Int, 2014, 2014: 150845. https://www.researchgate.net/publication/263863769_Apoptosis_and_Molecular_Targeting_Therapy_in_Cancer
|
| [20] |
Chatterjee M, Rancso C, Stuhmer T, et al. The Y-box binding protein YB-1 is associated with progressive disease and mediates survival and drug resistance in multiple myeloma[J]. Blood, 2008, 111(7): 3714-22. doi: 10.1182/blood-2007-05-089151
|
| [21] |
Banyard J, Bielenberg DR. The role of EMT and MET in cancer dissemination[J]. Connect Tissue Res, 2015, 56(5): 403-13. doi: 10.3109/03008207.2015.1060970
|
| [22] |
Eliseeva IA, Kim ER, Guryanov SG, et al. Y-box-binding protein 1(YB-1) and its functions[J]. Biochemistry (Mosc), 2011, 76(13): 1402-33. doi: 10.1134/S0006297911130049
|
| [23] |
Mo D, Fang H, Niu K, et al. Human Helicase RECQL4 Drives Cisplatin Resistance in Gastric Cancer by Activating an AKT-YB1-MDR1 Signaling Pathway[J]. Cancer Res, 2016, 76(10): 3057-66. doi: 10.1158/0008-5472.CAN-15-2361
|
| [24] |
Kaszubiak A, Kupstat A, Muller U, et al. Regulation of MDR1 gene expression in multidrug-resistant cancer cells is independent from YB-1[J]. Biochem Biophys Res Commun, 2007, 357(1): 295-301. doi: 10.1016/j.bbrc.2007.03.145
|
| [25] |
Mylona E, Melissaris S, Giannopoulou I, et al. Y-box-binding protein 1(YB1) in breast carcinomas: relation to aggressive tumor phenotype and identification of patients at high risk for relapse[J]. Eur J Surg Oncol, 2014, 40(3): 289-96. doi: 10.1016/j.ejso.2013.09.008
|
| [26] |
Xu M, Jin H, Xu CX, et al. miR-382 inhibits osteosarcoma metastasis and relapse by targeting Y box-binding protein 1[J]. Mol Ther, 2015, 23(1): 89-98. doi: 10.1038/mt.2014.197
|
| [27] |
Bernhardt A, Fehr A, Brandt S, et al. Inflammatory cell infiltration and resolution of kidney inflammation is orchestrated by the cold-shock protein Y-box binding protein-1[J]. Kidney Int, 2017, 92(5):1157-77. doi: 10.1016/j.kint.2017.03.035
|
| [28] |
Wang J, Djudjaj S, Gibbert L, et al. YB-1 orchestrates onset and resolution of renal inflammation via IL10 gene regulation[J]. J Cell Mol Med, 2017, 21(12): 3494-505. doi: 10.1111/jcmm.2017.21.issue-12
|
| [29] |
Luo C, Tetteh PW, Merz PR, et al. miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes[J]. J Invest Dermatol, 2013, 133(3): 768-75. doi: 10.1038/jid.2012.357
|
| [30] |
Wu S, Fu X, Huang J, et al. Genome-wide analysis of YB-1-RNA interactions reveals a novel role of YB-1 in miRNA processing in glioblastoma multiforme[J]. Nucleic Acids Res, 2015, 43(17): 8516-28. doi: 10.1093/nar/gkv779
|
| [31] |
Li D, Liu X, Zhou J, et al. Long noncoding RNA HULC modulates the phosphorylation of YB-1 through serving as a scaffold of extracellular signal-regulated kinase and YB-1 to enhance hepatocarcinogenesis[J]. Hepatology, 2017, 65(5): 1612-27. doi: 10.1002/hep.29010
|
| [32] |
Wei MM, Zhou YC, Wen ZS, et al. Long non-coding RNA stabilizes the Y-box-binding protein 1 and regulates the epidermal growth factor receptor to promote lung carcinogenesis[J]. Oncotarget, 2016, 7(37): 59556-71. http://www.ncbi.nlm.nih.gov/pubmed/27322209
|
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: